
CAS 2223677-62-9
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 prodotti.
Ref: 4Z-A-111009
5mgPrezzo su richiesta10mg1.335,00€25mg2.366,00€50mg3.944,00€100mgPrezzo su richiesta(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
CAS:(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)Purezza:95%Peso molecolare:469.48g/mol(S,E)-N-(4-((3,4-DIFLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE
CAS:Purezza:95%Peso molecolare:469.49301147460943-Fluoro-Afatinib
CAS:Prodotto controllatoFormula:C24H25F2N5O3Colore e forma:NeatPeso molecolare:469.4843-Fluoro-afatinib
CAS:3-Fluoro-afatinib is a potent anticancer drug that belongs to the class of kinase inhibitors. It is an analog of afatinib, which is used in the treatment of various types of cancer. 3-Fluoro-afatinib has been shown to inhibit the activity of certain protein kinases that are involved in tumor growth and proliferation. This drug induces apoptosis in human cancer cells by inhibiting the phosphorylation of specific proteins that are essential for cell survival. 3-Fluoro-afatinib has been used as a medicinal agent in China for its potent anticancer properties. It is excreted primarily through urine and has demonstrated promising results in preclinical studies as a potential therapy for various types of cancer.Formula:C24H25F2N5O3Purezza:Min. 95%Peso molecolare:469.5 g/molRef: ST-EA-CP-A50006
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta






